Share General Information
Cinacalcet hydrochloride is a calcimimetic agent, meaning that it mimics the action of calcium. It is used to treat elevated calcium levels in the blood in the following disorders: secondary hyperparathyroidism (HPT) in patients with chronic kidney disease on dialysis; hypercalcemia in patients with parathyroid carcinoma; and severe hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy.
About the API
-
Japan DMF
-
Korea DMF
-
US DMF
Updates About Cinacalcet HCl
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
